prevention

8th Annual Prevention in Renal Disease

Toronto, Ontario, Canada

September 25-26, 2009
Westin Prince Hotel, Toronto

Please note: All content appearing below remains the property of the lecturer.
Any reproduction or rebroadcast without their consent is strictly prohibited

Program: Day 1

6:30 am Registration and Breakfast
7:00 am BREAKFAST SYMPOSIUM
SUPPORTED BY BRISTOL-MYERS SQUIBB & SANOFI-AVENTIS

Chair: Dr. Patrick Parfrey
Causes of Death in Chronic Kidney Disease Patients and their Prevention
7:45 am Introduction
Dimitrios G. Oreopoulos
Opening Remarks – Philip Marsden
REVIEW OF DUAL BLOCKADE: BENEFICIAL OR HARMFUL?
Chairs: Dr. Eli Friedman and Dr. Philip Marsden
8:00 - 8:30 am An overview of the rationale and literature review
Dr. David Cherney
8:30 - 9:00 am Should we change our practice?
Dr. Philip McFarlane
9:00 - 9:20 am DISCUSSION
9:20 - 9:50 am RESULTS OF A CANADIAN PREVENTION STUDY (THE CANPREVENT STUDY)
Dr. Brendan Barrett
9:50 - 10:00 am DISCUSSION
10:00 - 10:30 am Coffee Break - Visit Posters

SIMULTANEOUS SESSIONS
A: PREVENTION IN THE GERIATRIC PATIENT
Chairs: Dr. Stanley Fenton & Dr. Vanita Jassal
10:30 - 11:00 am Pitfalls in estimating renal failure in the elderly by eGFR: Role of Proteinuria
Dr. Richard Glassock
11:00 - 11:30 am Managing elderly persons with CKD stages 3-4
Dr. Vanita Jassal
11:30 - 12:00 pm Very old persons with CKD stage 5 and comorbidities: is Dialysis harmful?
Dr. Eli Friedman
12:00 - 12:30 pm DISCUSSION

B: PREVENTION IN THE PEDIATRIC PATIENT
Chair: Dr. Guido Filler
10:30 - 11:00 am Prenatal determinants for maximum nephron endowment at birth, thereby reducing CKD later in life.
Dr. Susan Bagby
11:00 - 11:30 am The role of Vitamin D for the prevention of diabetes mellitus and diabetic nephropathy
Dr. Shayne Taback
11:30 - 12:00 pm Prevention of CKD in patients with disorders of the complement system.
Dr. Christopher Licht
12:00 - 12:30 pm DISCUSSION
12:30 - 1:30 pm Lunch
1:30 - 3:30 pm INTERACTIVE SESSION
With Drs. Bargman, Cattran, Appel
Vexing problems in lupus: Bargman Vexing problems in lupus: Appel Vexing problems in lupus: Cattran/Herzenberg
3:30 - 4:00 pm Coffee Break - Visit Posters

PREVENTION OF IATROGENIC NEPHROPATHIES
Chairs: Dr. Edward Cole and Dr. Sandra Donnelly
4:00 - 4:30 pm Prevention of nephrotoxicity of immunosuppressive agents in kidney transplantation
Dr. Jeffrey Zaltzman
4:30 - 5:00 pm Prevention of nephrotoxicity of the chemotherapeutic agent
Dr. Robert Richardson
5:00 - 5:30 pm Renal sparing strategies in the management of RCC
Dr. Antonio Finelli
5:30 - 6:00 pm DISCUSSION
6:00 - 8:00 pm Reception - Dinner

Program: Day 2

7:00-8:00 am BREAKFAST LECTURE
An interactive session on ACEs/ARBs and Albuminuria Review and Implications of Clincial Studies
CHAIR: Dr. Sheldon Tobe
The DROP Study
Dr. Jordan Weinstein
IDNT and IRMA II Study
Dr. Danny Sapir
The SMART Study
Dr. Andrew Steele

Discussion
PREVENTION IN PRIMARY GLOMERULAR DISEASE
Chair: Dr. Daniel Cattran
8:00 - 8:30 am IgA Nephropathy
Dr. John Feehally
8:30 - 9:00 am Membranous nephropathy
Dr. Daniel Cattran
9:00 - 9:30 am Focal Sclerosis
Dr. Jerry Appel
9:30 - 10:00 am DISCUSSION
10:00 - 10:30 am Coffee Break - Visit Posters
SIMULTANEOUS SESSION
A: PREVENTION OF SECONDARY NEPHROPATHIES
Chairs: Dr. Carl Cardella and Dr. John Dirks
10:30 - 11:00 am Viral infections (Hepatitis C) (including nephrotoxicity of Rx used in its treatment)
Dr. Warren Kupin
11:00 - 11:30 am Viral infections (HIV) (including nephrotoxicity of Rx used for its treatment)
Dr. Christina Wyatt
11:30 - 12:00 pm Paraproteinemias (myeloma - amyloidosis)
Dr. Joseph Mikhael
12:00 - 12:30 pm DISCUSSION
B: PREVENTION IN PSYCHONEPHROLOGY
Chairs: Dr. Marta Novak and Dr. Paul Kimmel
10:30 - 11:00 am Depression
Dr. Paul Kimmel
11:00 - 11:30 am Coping with the Difficult Patient
Dr. Gavril Hercz
11:30 - 12:00 pm Sleep Disorders
Dr Marta Novak
12:00 - 12:30 pm DISCUSSION
12:30 - 1:30 pm Lunch
1:30 - 2:30 pm Poster Session
PREVENTION OF COMPLICATIONS IN THE DIALYSIS PATIENT
Hemodialysis:
Chair: Dr. Robert Richardson
2:30 - 2:50 pm Intradialytic hypotension
Dr. Sandra Donnelly
2:50 - 3:10 pm Prevention of secondary Hyperparathyroidism in the Dialysis Patient: A paradigm shiftba
Dr. Darryl Quarles
3:10 - 3:30 pm DISCUSSION
Peritoneal Dialysis:
Chairs: Dr. Paul Tam and Dr. David Naimark
3:30 - 3:50 pm Growth of PD: Impact of home assistance
Dr. Matthew Oliver
3:50 - 4:10 pm Prevention of Ultrafiltration Failure in PD
Dr. Joanne Bargman
4:10 - 4:30 pm DISCUSSION